almitrine has been researched along with Aging in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (33.33) | 18.7374 |
1990's | 9 (60.00) | 18.2507 |
2000's | 1 (6.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Devissaguet, M | 1 |
Averet, N; Carbonneau, A; Clerc, M; Dubourg, L; Guerin, B; Jumelle-Laclau, M; Leverve, X; Rigoulet, M | 1 |
Sebban, C | 2 |
Laurent, B; Poitrenaud, J; Sebban, C | 1 |
Li, SW | 1 |
Allain, H; Bentué-Ferrer, D | 1 |
Bradford, A; Cantillon, D; McGuire, M | 1 |
Benzi, G; Curti, D | 1 |
Guez, D | 1 |
Guez, D; Malbezin, M; Schatz, C; Sebban, C; Tesolin, B | 1 |
Carbonin, PU; Cattelin, F; Gemma, A; Greco, A; Pisanti, P | 1 |
Berthaux, P; Coulomb, B; Sebban, C; Tesolin, B | 1 |
Pastoris, O; Villa, RF | 1 |
Hanson, MA; McCooke, HB | 1 |
3 review(s) available for almitrine and Aging
Article | Year |
---|---|
Quantitative electroencephalography in aging brain and cerebrovascular disease: the effects of almitrine-raubasine.
Topics: Aging; Almitrine; Animals; Brain; Cerebrovascular Disorders; Drug Combinations; Electroencephalography; Humans; Neuroprotective Agents; Rats; Secologanin Tryptamine Alkaloids; Yohimbine | 1995 |
Clinical efficacy of almitrine-raubasine. An overview.
Topics: Aged; Aging; Almitrine; Clinical Trials as Topic; Cognition Disorders; Drug Combinations; Humans; Ischemia; Neuroprotective Agents; Retinal Vessels; Treatment Outcome; Yohimbine | 1998 |
A review of the EEG effects of the combination of almitrine and raubasine in animals and humans.
Topics: Aged; Aging; Almitrine; Animals; Drug Combinations; Electroencephalography; Humans; Rats; Secologanin Tryptamine Alkaloids; Yohimbine | 1990 |
2 trial(s) available for almitrine and Aging
Article | Year |
---|---|
Memory disorders in 8,037 elderly patients with age-associated memory impairment: multicenter trial with a 6-month follow-up under almitrine-raubasine.
Topics: Aged; Aged, 80 and over; Aging; Almitrine; Drug Combinations; Family Practice; Follow-Up Studies; Humans; Memory Disorders; Middle Aged; Neuroprotective Agents; Secologanin Tryptamine Alkaloids; Yohimbine | 1995 |
Efficacy of almitrine-raubasine in cognitive disorders of aging: a double-blind, placebo-controlled, clinical and psychometric study.
Topics: Aged; Aged, 80 and over; Aging; Almitrine; Cognition Disorders; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Psychological Tests; Psychometrics; Secologanin Tryptamine Alkaloids; Yohimbine | 1990 |
10 other study(ies) available for almitrine and Aging
Article | Year |
---|---|
[Pharmacological approach to a treatment of senescence and cerebrovascular deficiencies related to hypoxia. Application to 5023 SE].
Topics: Aging; Almitrine; Animals; Cerebrovascular Circulation; Cerebrovascular Disorders; Disease Models, Animal; Dogs; Drug Combinations; Glucose; Humans; Hypoxia, Brain; Neurons; Oxygen Consumption; Piperazines; Rabbits; Rats; Yohimbine | 1983 |
Relationships between age-dependent changes in the effect of almitrine on H(+)-ATPase/ATPsynthase and the pattern of membrane fatty acid composition.
Topics: Aging; Almitrine; Animals; Cholesterol; Fatty Acids; Intracellular Membranes; Lipid Metabolism; Male; Mitochondria, Liver; Phosphorus; Proton-Translocating ATPases; Rats; Rats, Wistar | 1993 |
Stroke and functional rehabilitation: the Chinese experience.
Topics: Aged; Aged, 80 and over; Aging; Almitrine; Cerebrovascular Disorders; China; Drug Combinations; Female; Humans; Incidence; Male; Middle Aged; Neuroprotective Agents; Prevalence; Yohimbine | 1998 |
Effects of almitrine on diaphragm contractile properties in young and old rats.
Topics: Aging; Almitrine; Analysis of Variance; Animals; Animals, Newborn; Culture Techniques; Diaphragm; Female; Male; Models, Animal; Muscle Contraction; Muscle Fatigue; Probability; Rats; Rats, Wistar; Reference Values; Sensitivity and Specificity | 2002 |
Role of synaptosomal enzymatic alterations and drug treatment in brain aging.
Topics: Aging; Almitrine; Animals; Brain; Citrate (si)-Synthase; Electron Transport Complex IV; Glucosephosphate Dehydrogenase; Male; Papaverine; Phosphofructokinase-1; Pyruvate Dehydrogenase Complex; Rats; Rats, Inbred Strains; Secologanin Tryptamine Alkaloids; Synaptosomes; Yohimbine | 1990 |
Long-term effects and safety of almitrine-raubasine in age-associated cognitive decline.
Topics: Aged; Aging; Almitrine; Cognition Disorders; Drug Combinations; Female; Humans; Male; Middle Aged; Secologanin Tryptamine Alkaloids; Time Factors; Yohimbine | 1990 |
Comparative effects of almitrine and raubasine, singly and in combination, on electroencephalographic activity in young and old rats.
Topics: Aging; Almitrine; Animals; Brain; Drug Combinations; Electroencephalography; Injections, Intraperitoneal; Male; Piperazines; Random Allocation; Rats; Rats, Inbred Strains; Secologanin Tryptamine Alkaloids; Yohimbine | 1989 |
[Effects of aging and various pharmacologic agents on the brain energy metabolism in the course of post-hypoglycemic recuperation in the rat].
Topics: Adenosine Triphosphate; Aging; Almitrine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain; Central Nervous System Stimulants; Glucose; Hypoglycemia; Male; Phosphocreatine; Piperazines; Rats; Rats, Inbred Strains; Secologanin Tryptamine Alkaloids; Sodium Chloride; Time Factors; Yohimbine | 1987 |
[Exploration of the effects of duxil on the central nervous system by quantified electroencephalography].
Topics: Aged; Aging; Almitrine; Animals; Brain; Drug Combinations; Electroencephalography; Humans; Piperazines; Rats; Yohimbine | 1988 |
Respiration of conscious kittens in acute hypoxia and effect of almitrine bismesylate.
Topics: Acute Disease; Aging; Almitrine; Animals; Cats; Consciousness; Female; Hypoxia; Male; Oxygen; Physiology; Piperazines; Respiration; Tidal Volume; Time Factors; Wakefulness | 1985 |